HCW Biologics (HCWB) Short Interest Ratio & Short Volume $0.77 +0.06 (+8.45%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HCW Biologics Short Interest DataHCW Biologics (HCWB) has a short interest of 8,100 shares, representing 0.04% of the float (the number of shares available for trading by the public). This marks a -67.47% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 2.60 million shares to cover all short positions.Current Short Interest8,100 sharesPrevious Short Interest24,900 sharesChange Vs. Previous Month-67.47%Dollar Volume Sold Short$3,491.10Short Interest Ratio0.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares37,820,000 sharesFloat Size19,750,000 sharesShort Percent of Float0.04%Today's Trading Volume2,043,164 sharesAverage Trading Volume2,598,687 sharesToday's Volume Vs. Average79% Short Selling HCW Biologics? Sign up to receive the latest short interest report for HCW Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHCWB Short Interest Over TimeHCWB Days to Cover Over TimeHCWB Percentage of Float Shorted Over Time Ad DTILet’s be bluntLet me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now HCW Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20248,100 shares $3,491.10 -67.5%0.0%0.3 $0.43 10/15/202424,900 shares $13,944.00 -11.4%0.1%1.1 $0.56 9/30/202428,100 shares $15,157.14 +119.5%0.2%1.4 $0.54 9/15/202412,800 shares $7,808.00 +212.2%0.1%0.5 $0.61 8/31/20244,100 shares $1,890.10 -65.0%0.0%0.2 $0.46 8/15/202411,700 shares $5,861.70 +69.6%0.1%0.7 $0.50 Get the Latest News and Ratings for HCWB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20246,900 shares $4,165.53 -4.2%0.0%0.3 $0.60 7/15/20247,200 shares $5,040.00 -21.7%0.0%0.4 $0.70 6/30/20249,200 shares $5,952.40 +70.4%0.1%0.4 $0.65 6/15/20245,400 shares $6,048.00 +350.0%0.0%0.3 $1.12 5/31/20241,200 shares $1,308.00 -7.7%0.0%0.1 $1.09 5/15/20241,300 shares $1,508.00 -84.9%0.0%0.1 $1.16 4/30/20248,600 shares $12,040.00 +13.2%0.1%0.5 $1.40 4/15/20247,600 shares $12,312.00 -52.2%0.1%0.5 $1.62 3/31/202415,900 shares $27,825.00 -27.7%0.1%1 $1.75 3/15/202422,000 shares $33,660.00 -8.3%0.1%1.3 $1.53 2/29/202424,000 shares $35,280.00 +445.5%0.2%1.7 $1.47 2/15/20244,400 shares $5,030.08 +2.3%0.0%0.4 $1.14 1/31/20244,300 shares $4,945.00 -39.4%0.0%0.2 $1.15 1/15/20247,100 shares $8,378.00 -4.1%0.0%0.4 $1.18 12/31/20237,400 shares $9,065.00 -38.8%0.0%0.4 $1.23 12/15/202312,100 shares $13,431.00 -40.7%0.1%0.8 $1.11 11/30/202320,400 shares $22,032.00 -4.7%0.1%1.4 $1.08 11/15/202321,400 shares $19,688.00 +170.9%0.1%1.6 $0.92 10/31/20237,900 shares $13,272.00 -16.8%0.0%0.6 $1.68 10/15/20239,500 shares $17,290.00 -10.4%0.1%1.3 $1.82 9/30/202310,600 shares $20,140.00 -53.1%0.1%1.3 $1.90 9/15/202322,600 shares $45,426.00 +5.6%0.1%2.5 $2.01 8/31/202321,400 shares $38,734.00 -14.4%0.1%1.9 $1.81 8/15/202325,000 shares $52,000.00 +7.8%0.1%1.4 $2.08 7/31/202323,200 shares $47,328.00 -13.4%0.1%1.2 $2.04 7/15/202326,800 shares $56,816.00 -23.7%0.2%1.4 $2.12 6/30/202335,100 shares $76,167.00 +44.4%0.2%1.8 $2.17 6/15/202324,300 shares $51,759.00 +86.9%0.1%1.2 $2.13 5/31/202313,000 shares $19,110.00 -13.3%0.1%0.7 $1.47 5/15/202315,000 shares $22,051.50 -45.3%0.1%1 $1.47 4/30/202327,400 shares $39,146.38 -0.7%0.2%1.8 $1.43 4/15/202327,600 shares $41,400.00 +10.8%0.2%1.5 $1.50 3/31/202324,900 shares $34,884.90 +11.7%0.1%1.2 $1.40 3/15/202322,300 shares $30,105.00 -20.6%0.1%1 $1.35Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. 2/28/202328,100 shares $50,580.00 +53.6%0.2%1.3 $1.80 2/15/202318,300 shares $34,587.00 +140.8%0.1%0.8 $1.89 1/31/20237,600 shares $14,744.00 -68.3%0.0%0.4 $1.94 1/15/202324,000 shares $51,600.00 +31.2%0.2%1.2 $2.15 12/30/202218,300 shares $35,040.84 +19.6%0.1%1.1 $1.91 12/15/202215,300 shares $30,600.00 -41.6%0.1%0.8 $2.00 11/30/202226,200 shares $55,302.96 +84.5%0.2%1.2 $2.11 11/15/202214,200 shares $31,240.00 +23.5%0.1%0.6 $2.20 10/31/202211,500 shares $25,760.00 -45.2%0.1%0.5 $2.24 10/15/202221,000 shares $46,830.00 -58.7%0.1%0.9 $2.23 9/30/202250,900 shares $116,561.00 +216.2%0.3%2.4 $2.29 9/15/202216,100 shares $39,284.00 +35.3%0.1%0.9 $2.44 8/31/202211,900 shares $30,542.54 -7.8%0.1%0.7 $2.57 8/15/202212,900 shares $28,767.00 -30.7%0.1%1 $2.23 7/31/202218,600 shares $44,454.00 +78.9%0.1%1.4 $2.39 7/15/202210,400 shares $24,232.00 -38.1%0.1%0.8 $2.33 6/30/202216,800 shares $36,960.00 +24.4%0.1%0.9 $2.20 6/15/202213,500 shares $32,265.00 -9.4%0.1%0.5 $2.39 5/31/202214,900 shares $30,992.00 -54.6%0.1%0.5 $2.08 5/15/202232,800 shares $64,616.00 +9.0%0.2%1.1 $1.97 4/30/202230,100 shares $70,434.00 -32.5%0.2%0.9 $2.34 4/15/202244,600 shares $121,312.00 -3.5%0.3%0.9 $2.72 3/31/202246,200 shares $126,126.00 -11.0%0.3%0.7 $2.73 3/15/202251,900 shares $106,914.00 +19.6%0.4%0.6 $2.06 2/28/202243,400 shares $95,046.00 -32.4%0.3%0.4 $2.19 2/15/202264,200 shares $150,870.00 -18.5%0.5%0.6 $2.35 1/31/202278,800 shares $168,632.00 -39.3%0.6%0.5 $2.14 1/15/2022129,800 shares $288,156.00 +5.3%1.1%0 $2.22 12/31/2021123,300 shares $286,056.00 +35.5%1.0%0 $2.32 12/15/202191,000 shares $249,340.00 -3.1%0.7%0 $2.74 11/30/202193,900 shares $269,493.00 -0.2%0.8%0 $2.87 11/15/202194,100 shares $278,536.00 -39.5%0.8%0 $2.96 10/29/2021155,400 shares $694,638.00 +60.0%1.3%0.1 $4.47 10/15/202197,100 shares $254,402.00 No Change0.8%0.6 $2.62 9/30/202197,100 shares $309,749.00 +13.0%0.8%0.7 $3.19 9/15/202185,900 shares $325,561.00 +30.2%0.7%0.6 $3.79 8/31/202166,000 shares $262,020.00 +1,366.7%0.8%0.4 $3.97 8/13/20214,500 shares $23,040.00 No Change0.1%0 $5.12 HCWB Short Interest - Frequently Asked Questions What is HCW Biologics' current short interest? Short interest is the volume of HCW Biologics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 8,100 shares of HCWB short. 0.04% of HCW Biologics' shares are currently sold short. Learn More on HCW Biologics' current short interest. What is a good short interest percentage for HCW Biologics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of HCW Biologics' floating shares are currently sold short. Is HCW Biologics' short interest increasing or decreasing? HCW Biologics saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 8,100 shares, a drop of 67.5% from the previous total of 24,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is HCW Biologics' float size? HCW Biologics currently has issued a total of 37,820,000 shares. Some of HCW Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. HCW Biologics currently has a public float of 19,750,000 shares. How does HCW Biologics' short interest compare to its competitors? 0.04% of HCW Biologics' shares are currently sold short. Here is how the short interest of companies compare to HCW Biologics: Enlivex Therapeutics Ltd. (0.75%), Vaxart, Inc. (4.95%), INmune Bio, Inc. (15.70%), Scilex Holding (9.50%), Century Therapeutics, Inc. (10.24%), Monopar Therapeutics Inc. (3.58%), Cellectis S.A. (0.28%), Tiziana Life Sciences Ltd (0.37%), Coya Therapeutics, Inc. (1.40%), Immunic, Inc. (5.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short HCW Biologics stock? Short selling HCWB is an investing strategy that aims to generate trading profit from HCW Biologics as its price is falling. HCWB shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against HCW Biologics? A short squeeze for HCW Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HCWB, which in turn drives the price of the stock up even further. How often is HCW Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HCWB, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Enlivex Therapeutics Short Squeeze Vaxart Short Squeeze INmune Bio Short Squeeze Scilex Short Squeeze Century Therapeutics Short Squeeze Monopar Therapeutics Short Squeeze Cellectis Short Squeeze Tiziana Life Sciences Short Squeeze Coya Therapeutics Short Squeeze Immunic Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HCWB) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
